ClinicalTrials.Veeva

Menu

Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Bipolar Disorder

Study type

Observational

Funder types

Industry

Identifiers

NCT00927420
NIS-NES-DUM-2009/1

Details and patient eligibility

About

The purpose of this study is to estimate adherence to treatment in bipolar patients, to characterize patients based on adherence degree and to describe the variables linked to poor adherence to treatment in real-life practice.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with bipolar disorder I or II DSM-IV
  • Patients treated with at least one oral antipsychotic
  • Subjects able to read and write

Exclusion criteria

  • Patients participating in clinical trials

Trial design

300 participants in 1 patient group

1
Description:
Patients diagnosed with bipolar disorder I or II (DSM-IV) in ambulatory settings

Trial contacts and locations

24

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems